BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22554253)

  • 21. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes.
    Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL
    Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
    Zhang Y; Zou J; Yang J; Yao Z
    Curr Alzheimer Res; 2015; 12(4):384-97. PubMed ID: 25817256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.
    Vasilevko V; Pop V; Kim HJ; Saing T; Glabe CC; Milton S; Barrett EG; Cotman CW; Cribbs DH; Head E
    Neurobiol Dis; 2010 Sep; 39(3):301-10. PubMed ID: 20451612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
    Head E; Pop V; Vasilevko V; Hill M; Saing T; Sarsoza F; Nistor M; Christie LA; Milton S; Glabe C; Barrett E; Cribbs D
    J Neurosci; 2008 Apr; 28(14):3555-66. PubMed ID: 18385314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.
    Das P; Howard V; Loosbrock N; Dickson D; Murphy MP; Golde TE
    J Neurosci; 2003 Sep; 23(24):8532-8. PubMed ID: 13679422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease.
    Webster SJ; Mruthinti S; Hill WD; Buccafusco JJ; Terry AV
    Neuromolecular Med; 2012 Jun; 14(2):119-30. PubMed ID: 22415896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.
    Vehmas AK; Borchelt DR; Price DL; McCarthy D; Wills-Karp M; Peper MJ; Rudow G; Luyinbazi J; Siew LT; Troncoso JC
    DNA Cell Biol; 2001 Nov; 20(11):713-21. PubMed ID: 11788049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.
    Wang CM; Devries S; Camboni M; Glass M; Martin PT
    Neurobiol Dis; 2010 Sep; 39(3):409-22. PubMed ID: 20493257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.
    Orgogozo JM; Gilman S; Dartigues JF; Laurent B; Puel M; Kirby LC; Jouanny P; Dubois B; Eisner L; Flitman S; Michel BF; Boada M; Frank A; Hock C
    Neurology; 2003 Jul; 61(1):46-54. PubMed ID: 12847155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
    Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
    Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
    Lemere CA
    Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid.
    Chen G; Chen KS; Kobayashi D; Barbour R; Motter R; Games D; Martin SJ; Morris RG
    J Neurosci; 2007 Mar; 27(10):2654-62. PubMed ID: 17344403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta).
    Gandy S; DeMattos RB; Lemere CA; Heppner FL; Leverone J; Aguzzi A; Ershler WB; Dai J; Fraser P; St George Hyslop P; Holtzman DM; Walker LC; Keller ET
    Mech Ageing Dev; 2004 Feb; 125(2):149-51. PubMed ID: 15037022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglial alterations in human Alzheimer's disease following Aβ42 immunization.
    Zotova E; Holmes C; Johnston D; Neal JW; Nicoll JA; Boche D
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):513-24. PubMed ID: 21166690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of non-viral amyloid-β DNA vaccines on amyloid-β reduction and safety in rhesus monkeys.
    Tokita Y; Kaji K; Lu J; Okura Y; Kohyama K; Matsumoto Y
    J Alzheimers Dis; 2010; 22(4):1351-61. PubMed ID: 20930304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.
    Petrushina I; Ghochikyan A; Mktrichyan M; Mamikonyan G; Movsesyan N; Davtyan H; Patel A; Head E; Cribbs DH; Agadjanyan MG
    J Neurosci; 2007 Nov; 27(46):12721-31. PubMed ID: 18003852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of Tg-APPswe/PSEN1dE9 mice with Aβ3-10-KLH vaccine prevents synaptic deficits of Alzheimer's disease.
    Meng Y; Ding L; Zhang H; Yin W; Yan Y; Cao Y
    Behav Brain Res; 2017 Aug; 332():64-70. PubMed ID: 28577919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.
    Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D
    Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.